Global Expansion of Linezolid-Resistant Coagulase-Negative Staphylococci
Coagulase-negative staphylococci (CoNS) for a long time were considered avirulent constituents of the human and warm-blooded animal microbiota. However, at present, S. epidermidis, S. haemolyticus, and S. hominis are recognized as opportunistic pathogens. Although linezolid is not registered for the...
Main Authors: | Vladimir Gostev, Semen Leyn, Alexander Kruglov, Daria Likholetova, Olga Kalinogorskaya, Marina Baykina, Natalia Dmitrieva, Zlata Grigorievskaya, Tatiana Priputnevich, Lyudmila Lyubasovskaya, Alexey Gordeev, Sergey Sidorenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2021.661798/full |
Similar Items
-
COMPARISON OF THE CLINICAL ACTIVITY OF TWO OXAZOLIDINONES – LINEZOLID AND TEDIZOLIDE: UNJUSTIFIED EXPECTATIONS
by: N. V. Dmitrieva, et al.
Published: (2018-11-01) -
Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical Trials
by: Gregory J. Moran, et al.
Published: (2018-09-01) -
New and old oxazolidinones: tedizolid vs. linezolid
by: Dekhnich A.V., et al.
Published: (2017-05-01) -
Tedizolid Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis
by: Shao-Huan Lan, et al.
Published: (2019-09-01) -
Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China
by: Shu’an Wen, et al.
Published: (2021-08-01)